Shifting Cell and Gene Therapy Discourse

Recently, I had the privilege to be a part of BrightTALK panel where we shared insights and strategies to help healthcare professionals stay at the forefront of this rapidly evolving field. The conversation on this panel, client discussions, and recent market study(s) has made it clear for us that our research on industry discourse in 2022 must be updated. In addition to the concerns around patient access, ?the current discourse includes concerns regarding viability of the CGT business.

For details on conditions that must be true to sustain CGT and affect patient outcomes, please listen to the panel discussion.

https://www.brighttalk.com/webcast/19441/621637?utm_source=XtelligentHealthcareMedia&utm_medium=brighttalk&utm_campaign=621637

#CGT, #celltherapies, #genetherapies, #cellandgenetherapies

Gaurav Shah Adam Volini Puneet Maheshwari Barry Heavey Kailash Swarna Lena Walton Kealy Walters